Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Veracyte (VCYT) EBIT: 2011-2024

Historic EBIT for Veracyte (VCYT) over the last 14 years, with Dec 2024 value amounting to $16.1 million.

  • Veracyte's EBIT rose 90.95% to $22.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.8 million, marking a year-over-year increase of 205.17%. This contributed to the annual value of $16.1 million for FY2024, which is 118.81% up from last year.
  • Latest data reveals that Veracyte reported EBIT of $16.1 million as of FY2024, which was up 118.81% from -$85.8 million recorded in FY2023.
  • In the past 5 years, Veracyte's EBIT registered a high of $16.1 million during FY2024, and its lowest value of -$85.8 million during FY2023.
  • Its 3-year average for EBIT is -$36.9 million, with a median of -$41.1 million in 2022.
  • As far as peak fluctuations go, Veracyte's EBIT tumbled by 133.95% in 2020, and later surged by 118.81% in 2024.
  • Over the past 5 years, Veracyte's EBIT (Yearly) stood at -$35.4 million in 2020, then slumped by 131.44% to -$81.9 million in 2021, then soared by 49.84% to -$41.1 million in 2022, then slumped by 108.84% to -$85.8 million in 2023, then skyrocketed by 118.81% to $16.1 million in 2024.